Jazz Pharmaceuticals will buy North Carolina biotech Chimerix for $935 million in cash, the companies said Wednesday morning.

Bayer said Wednesday its pharmaceuticals unit will likely see a decline in sales in 2025 as the company reported another set ...

Eli Lilly opens unprecedented public submission process for US states to pitch potential manufacturing sites as part of $27B ...

Persica Pharmaceuticals reports positive Phase 1b results for PP353, a two-dose antibiotic combining linezolid and iohexol, ...

China will ban the import of DNA sequencers from San Diego-based Illumina, an apparent response to additional US tariffs.

A small Swiss biotech has terminated a mid-stage test of a new type of oral drug for people with Alzheimer's disease, ...

Edenbridge Pharmaceuticals received this year's first untitled letter from the FDA's drug promotion office over misleading ...

DOGE says that it has terminated the leases of 30 FDA offices and buildings, including a 52,000 square-foot St. Louis-based ...

Teladoc faces flat revenue forecasts through 2025, prompting business model shifts. Analysts are hopeful Teladoc’s efforts ...

Cerebral CEO David Mou steps down, replaced by interim CEO Brian Reinken. Mou stays as CMO and launches new mental health ...

BeiGene's Tevimbra approved for ESCC with chemo, Tenaya plans $52.5M offering, Evotec gets $20M from Bristol Myers Squibb, and Osivax raises €10M for flu vaccine research ...

The board of immunology biotech Acelyrin has rejected the buyout offer from Tang Capital's shell company Concentra ...